Heart rehab program aims to ease chest pain in microvascular disease
NCT ID NCT05810051
First seen Jan 27, 2026 · Last updated May 14, 2026 · Updated 19 times
Summary
This study tests whether a 36-session cardiac rehabilitation program, added to standard medication, can improve quality of life and reduce chest pain in people with coronary microvascular disease (small vessel heart disease). About 204 participants with angina and confirmed microvascular dysfunction will be randomly assigned to medication alone or medication plus rehab. The main outcome is change in a heart-related quality-of-life questionnaire after 4 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY MICROVASCULAR DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
OLV Aalst
Aalst, East-Flanders, 9300, Belgium
Conditions
Explore the condition pages connected to this study.